Benchmark your enzyme development and scale-up programmes against proven strategies taken by Pfizer, Dr Reddy’s and Genecor.
Optimise enzyme application and ensure successful product developmentand scale up.
Meet the growing demand for cheaper and sustainability chemistry with practical advice from GSK, Merck and BASF.
Advance enzyme operational stability and immobilisation to reaction conditions with advice from Exeter’s Biocatalysis Centre.
Futureproof your business with latest research into new and emerging enzymes.
Bridge the gap between chemists, biochemists and biologics to accelerate and improve enzyme development - insight from Prof Andreas Liese.
Network, partner and collaborate with key biocatalysis decision-makers from the pharma, fine chemicals, agrow, bioploymer and personal care industry, academia and key chemical suppliers.
Wednesday March 19, 2014 at 8:00 am, ends Thursday March 20, 2014 at 5:35 pm
Conference Only: From £1,299.00
Artists / Speakers: Karen Holt-Tiffin, Head of Biocatalysis, Dr Reddy's Laboratories, UKDavid Estell, Research Fellow Chemical R&D, Genecor, USA • Professor Andreas Kuenkel, Head of research Biopolymers, BASF, Germany • Nicholas Turner, Professor of Chemical Biology, University of Manchester, UK • Dr Anton Glieder, CEO, Austrian Centre of Industrial Biotechnology GmbH, Austria • Professor Marco Fraaije, Enzyme Engineering, University of Groningen, Netherlands • Dr Pierre Mosan, INSA de Toulouse, France • Dr Bernhard Hauer, Professor and Director at The Institute for Technical Biochemistry, University of Stuttgart, Germany • Professor Andreas Liese, Head of Institute of Technical Biocatalysis, Hamburg University of Technology, Germany • Professor Jennifer LittleChild, Director, Exeter Biocatalysis Centre, uk.